{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,24]],"date-time":"2026-04-24T19:33:44Z","timestamp":1777059224660,"version":"3.51.4"},"reference-count":15,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2003,11,1]],"date-time":"2003-11-01T00:00:00Z","timestamp":1067644800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Pharmaceutical Sciences"],"published-print":{"date-parts":[[2003,11]]},"DOI":"10.1002\/jps.10486","type":"journal-article","created":{"date-parts":[[2003,10,31]],"date-time":"2003-10-31T20:22:32Z","timestamp":1067631752000},"page":"2317-2325","source":"Crossref","is-referenced-by-count":27,"title":["Once\u2010a\u2010Day Controlled\u2010Release Dosage Form of Divalproex Sodium II: Development of a Predictive In Vitro Drug Release Method"],"prefix":"10.1016","volume":"92","author":[{"given":"Yihong","family":"Qiu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Garren","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.","family":"Samara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G.","family":"Cao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Abraham","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H.S.","family":"Cheskin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K.R.","family":"Engh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1002\/jps.10486_bb0010","unstructured":"Depakote\u00ae Tablet. 2002. Physicians' desk reference."},{"key":"10.1002\/jps.10486_bb0015","doi-asserted-by":"crossref","first-page":"1166","DOI":"10.1002\/jps.10385","article-title":"Once\u2010a\u2010day controlled\u2010release dosage form of divalproex sodium I: Formulation design and in vitro\/in vivo investigations","volume":"92","author":"Qiu","year":"2003","journal-title":"J Pharm Sci"},{"key":"10.1002\/jps.10486_bb0020","unstructured":"Food and Drug Administration. 1997. Guidance for industry, extended release oral dosage forms: Development, evaluation, and application of in vitro\/in vivo correlations."},{"key":"10.1002\/jps.10486_bb0025","series-title":"Handbook of pharmaceutical controlled release technology","first-page":"465","article-title":"Reserach and development aspects of oral controlled\u2010release dosage forms","author":"Qiu","year":"2000"},{"key":"10.1002\/jps.10486_bb0030","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1023\/A:1015922629207","article-title":"The development of USP dissolution and drug release standards","volume":"7","author":"Cohen","year":"1990","journal-title":"Pharm Res"},{"key":"10.1002\/jps.10486_bb0035","unstructured":"Pharmacopeial Forum. 1993. In vitro and in vivo evaluation of dosage forms. 19: 5366\u20135379."},{"key":"10.1002\/jps.10486_bb0040","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1023\/A:1016494314263","article-title":"Report of the workshop on controlled release dosage forms: Issues and controversies","volume":"4","author":"Skelly","year":"1987","journal-title":"Pharm Res"},{"key":"10.1002\/jps.10486_bb0045","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/0378-5173(96)04561-9","article-title":"Dissolution testing for sustained or controlled release oral dosage forms and correlation with in vivo data: Challenges and opportunities","volume":"140","author":"Khan","year":"1996","journal-title":"Int J Pharm"},{"key":"10.1002\/jps.10486_bb0050","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1007\/BF03220015","article-title":"In vitro\/in vivo correlations in biopharmaceutics: Scientific and regulatory implications","volume":"18","author":"Skelly","year":"1993","journal-title":"Eur J Drug Metab Pharmacokinet"},{"key":"10.1002\/jps.10486_bb0055","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1007\/BF03220004","article-title":"Perspectives of in vivo dissolution tests in establishing in vitro\/in vivo correlations","volume":"18","author":"Siewert","year":"1993","journal-title":"Eur J Drug Metab Pharmacokinet"},{"key":"10.1002\/jps.10486_bb0060","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1023\/A:1015970512368","article-title":"In vitro and in vivo testing and correlation for oral controlled\/modified\u2010release dosage forms","volume":"7","author":"Skelly","year":"1990","journal-title":"Pharm Res"},{"key":"10.1002\/jps.10486_bb0065","first-page":"8","article-title":"Dissolution assay development for in vitro\u2010in vivo correlations","volume":"6","author":"Rohrs","year":"2003","journal-title":"Am Pharmaceut Rev"},{"key":"10.1002\/jps.10486_bb0070","series-title":"Handbook of pharmaceutical controlled release technology","first-page":"527","article-title":"In vitro\/in vivo correlations in the development of solid controlled\u2010release dosage forms","author":"Qiu","year":"2000"},{"key":"10.1002\/jps.10486_bb0075","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/BF03257392","article-title":"Pharmacokinetics of multiple oral dose divalproex sodium after intravenous loading dose administration in healthy volunteers","volume":"7","author":"Cavanaugh","year":"1994","journal-title":"Drug Invest"},{"key":"10.1002\/jps.10486_bb0080","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/S0378-5173(02)00622-1","article-title":"Design of pH\u2010independent controlled release matrix tablets for acidic drugs","volume":"252","author":"Rao","year":"2003","journal-title":"Int J Pharm"}],"container-title":["Journal of Pharmaceutical Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022354916313570?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022354916313570?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,2,18]],"date-time":"2019-02-18T11:51:44Z","timestamp":1550490704000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022354916313570"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2003,11]]},"references-count":15,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2003,11]]}},"alternative-id":["S0022354916313570"],"URL":"https:\/\/doi.org\/10.1002\/jps.10486","relation":{},"ISSN":["0022-3549"],"issn-type":[{"value":"0022-3549","type":"print"}],"subject":[],"published":{"date-parts":[[2003,11]]}}}